A previous study reported that, compared to the Ala-to-Cys mutant of GPX4, the Ala-to-Sec mutant contributed to GPX4 binding of RSL3, a selective ferroptosis activator for tumor cells carrying oncogenic RAS 19. This evidence concerns the gene GPX4 and neoplasm.